OCUGEN, INC. Increase (Decrease) in Other Noncurrent Assets
OCUGEN, INC. (OCGN) reported Increase (Decrease) in Other Noncurrent Assets of $750.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-22.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2019-03-22
- OCUGEN, INC. increase (decrease) in other noncurrent assets for the quarter ending 2018-12-31 was $375.00K.
- OCUGEN, INC. increase (decrease) in other noncurrent assets for the quarter ending 2018-09-30 was $187.00K.
- OCUGEN, INC. increase (decrease) in other noncurrent assets for the quarter ending 2018-06-30 was -$187.00K.
- OCUGEN, INC. increase (decrease) in other noncurrent assets for the quarter ending 2018-03-31 was $375.00K.
- OCUGEN, INC. increase (decrease) in other noncurrent assets for fiscal 2018 was $750.00K.
- OCUGEN, INC. increase (decrease) in other noncurrent assets for fiscal 2014 was -$402.00K.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2018-12-31 | $375.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $562.00K derived: sum of 2 quarters · filed 2019-03-22 | $375.00K derived: sum of 3 quarters · filed 2019-03-22 | $750.00K 10-K · filed 2019-03-22 |
| 2018-09-30 | $187.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $0.00 derived: sum of 2 quarters · filed 2018-11-08 | $375.00K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | -$187.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $188.00K 10-Q · filed 2018-08-09 | ||
| 2018-03-31 | $375.00K 10-Q · filed 2018-05-10 | |||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$467.00K 10-Q · filed 2016-11-10 | ||
| 2015-06-30 | -$467.00K 10-Q · filed 2016-08-11 | |||
| 2014-12-31 | -$481.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | -$539.00K derived: sum of 2 quarters · filed 2016-03-10 | -$402.00K 10-K · filed 2016-03-10 | |
| 2014-09-30 | -$58.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $79.00K 10-Q · filed 2015-11-12 | ||
| 2014-06-30 | $137.00K 10-Q · filed 2015-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |